Although mutations in KIT are recognized as key drivers of clonal evolution in both germ cell tumor and hematological malignancies, the clinical and genomic interactions between GCT and SM remain largely unexplored, particularly in the pediatric population (4). This evidence concerns the gene KIT and germ cell tumor.